Locations:
Search IconSearch

Studying Augmented Reality Visual Cues to Treat Freezing of Gait in Parkinson’s

Recently launched first-of-kind study aims to address an unmet therapeutic need

23-NEU-3559066-augmented-reality-visual-gait-cues_650x450

Freezing of gait (FOG) eventually develops in more than half of people with Parkinson’s disease (PD). While it is generally not effectively managed with medications or surgical treatments, FOG can be ameliorated by visual gait cues such as parallel floor lines. However, the real-world applicability of such gait cues is limited. New research now underway at Cleveland Clinic is exploring whether augmented reality (AR) can help change that and expand the utility of visual gait cues to treat FOG in people with PD.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Defining the challenge

FOG is a treatment priority in PD because it is associated with falls, morbidity and mortality. While visual gait cueing has utility in reducing FOG, it requires alteration of physical spaces that is simply not feasible at scale. For instance, parallel floor lines cannot be overlaid on all the surfaces a patient with PD is likely to traverse. Other types of visual cues, like projected laser lines, have some promise but could potentially interfere with social interactions.

“There is a need for cueing techniques that are on-demand and perceptible only to the patient,” says Cleveland Clinic movement disorders neurologist James Liao, MD, PhD. “The good news is that recent advances in augmented reality are making this possible.”

Building on those advances, Dr. Liao is leading a study in which AR glasses are used to digitally project cues that are visible only to the wearer, in an effort to improve PD-related FOG. The study is receiving funding support from the American Parkinson Disease Association.

person wearing augmented reality goggles with a hand control

Photo of a healthy volunteer wearing the augmented reality glasses and holding the hand control used in the study.

Assessment of six different cue conditions

The study is enrolling 36 patients with PD and FOG to complete an obstacle course-like gait task under six visual cue conditions:

  • No cue
  • Conventional cue
  • Constant-on AR
  • AR hand-triggered by patient (activated when the patient clicks a button)
  • AR eye-triggered by patient (activated when the patient looks down)
  • Examiner-triggered AR

The AR cue is a collection of images that appear on the floor at the glasses-wearing patient’s feet and are designed to mimic laser lines projected onto the floor (see video example).

Advertisement

Video demonstrating hand-triggered visual cues as seen by a healthy volunteer wearing augmented reality glasses.

Patients’ gait is assessed both by video capture and by wireless sensors on the body that monitor the movement of each limb. The various cue conditions are used to determine whether patients improve with conventional cues, how intermittent cues perform relative to constant-on cues, and how cues triggered by an examiner perform relative to patients’ self-triggered cues.

Potential clinical and research benefits

“If successful, this will be the first investigation to show that augmented reality cues can improve freezing of gait,” Dr. Liao notes. “It could lead to widespread adoption of AR-assisted cueing devices for the treatment of freezing of gait.”

He adds that the study will also inform future AR-based gait research in PD, including whether to prioritize development of closed-loop cues (i.e., automatically triggered) or development of constant-on or patient-triggered intermittent cues.

“By comparing freezing-of-gait propensity across cue mechanisms, we may gain insight into the mechanisms of freezing of gait, which remain incompletely understood,” Dr. Liao says. “We believe this project will lead to reliable and discreet treatments for freezing of gait that can improve safety and quality of life for people with Parkinson’s disease.”

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad